Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Possible mechanism of phthalates-induced tumorigenesis.

Wang YC, Chen HS, Long CY, Tsai CF, Hsieh TH, Hsu CY, Tsai EM.

Kaohsiung J Med Sci. 2012 Jul;28(7 Suppl):S22-7. doi: 10.1016/j.kjms.2012.05.006. Epub 2012 Jul 10. Review.

2.

Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway.

Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Wang SC, Tsai EM.

FASEB J. 2012 Feb;26(2):778-87. doi: 10.1096/fj.11-191742. Epub 2011 Nov 2.

PMID:
22049059
3.

Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.

Lapinskas PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, Corton JC.

Toxicology. 2005 Feb 1;207(1):149-63.

PMID:
15590130
4.

PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY, McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA.

Crit Rev Toxicol. 2003;33(6):655-780. Review.

PMID:
14727734
5.

Role of the peroxisome proliferator-activated receptor alpha in responses to diisononyl phthalate.

Valles EG, Laughter AR, Dunn CS, Cannelle S, Swanson CL, Cattley RC, Corton JC.

Toxicology. 2003 Sep 30;191(2-3):211-25.

PMID:
12965124
6.

Plastics and health risks.

Halden RU.

Annu Rev Public Health. 2010;31:179-94. doi: 10.1146/annurev.publhealth.012809.103714. Review.

PMID:
20070188
7.

Monitoring phthalate exposure in humans.

Latini G.

Clin Chim Acta. 2005 Nov;361(1-2):20-9. Review.

PMID:
16004980
8.

Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway.

Ito Y, Yamanoshita O, Asaeda N, Tagawa Y, Lee CH, Aoyama T, Ichihara G, Furuhashi K, Kamijima M, Gonzalez FJ, Nakajima T.

J Occup Health. 2007 May;49(3):172-82.

9.

Mechanisms of phthalate ester toxicity in the female reproductive system.

Lovekamp-Swan T, Davis BJ.

Environ Health Perspect. 2003 Feb;111(2):139-45. Review.

10.

Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.

Lai DY.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2004 May;22(1):37-55. Review.

PMID:
15845221
11.

Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.

Bility MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM.

Toxicol Sci. 2004 Nov;82(1):170-82. Epub 2004 Aug 13.

PMID:
15310864
12.

Carcinogenicity of general-purpose phthalates: structure-activity relationships.

Hirzy JW.

Drug Metab Rev. 1989;21(1):55-63. Review.

PMID:
2696636
14.

Phthalate esters as peroxisome proliferator carcinogens.

Warren JR, Lalwani ND, Reddy JK.

Environ Health Perspect. 1982 Nov;45:35-40. Review.

15.
16.

In utero exposure to phthalates and fetal development.

Latini G, Del Vecchio A, Massaro M, Verrotti A, DE Felice C.

Curr Med Chem. 2006;13(21):2527-34. Review.

PMID:
17017909
17.

Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract?

Corton JC, Lapinskas PJ.

Toxicol Sci. 2005 Jan;83(1):4-17. Epub 2004 Oct 20. Review.

PMID:
15496498
18.

A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis.

Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, Sonenshein GE, Sherr DH.

Biol Chem. 2006 Sep;387(9):1175-87. Review.

PMID:
16972784
19.

Personal care products and endocrine disruption: A critical review of the literature.

Witorsch RJ, Thomas JA.

Crit Rev Toxicol. 2010 Nov;40 Suppl 3:1-30. doi: 10.3109/10408444.2010.515563. Review.

PMID:
20932229
20.

Phthalate risks, phthalate regulation, and public health: a review.

Kamrin MA.

J Toxicol Environ Health B Crit Rev. 2009 Feb;12(2):157-74. doi: 10.1080/10937400902729226. Review.

PMID:
19235623

Supplemental Content

Support Center